全球消化道出血治療市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計消化道出血治療市場規模將從 2025 年的 9.6 億美元成長到 2034 年的 19.3 億美元，2026 年至 2034 年的複合年成長率為 8.06%。

隨著胃腸道疾病、潰瘍和大腸癌發生率的上升，治療胃腸道出血的市場也持續成長。人口老化和不健康的生活方式，包括過量飲酒和不良飲食習慣，都是導致發病率上升的因素。診斷技術的進步使得早期檢測成為可能，從而增加了對有效治療方案的需求。

關鍵成長要素包括微創內視鏡手術的引進、止血裝置的改善以及發展中地區醫療基礎設施的擴建。藥物治療、輸血服務和先進外科技術的進步正在改善治療效果。公眾意識的提高和急救醫療服務的改善也進一步推動了全球市場的發展。

預計未來成長將主要由內視鏡治療技術的創新和標靶藥物的研發推動。醫療保健支出的增加和保險覆蓋範圍的擴大有望改善患者獲得治療的機會。隨著醫療技術的進步和患者療效的提高，消化道出血治療市場預計將保持長期穩定的成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球消化道出血治療市場：依產品分類

• 市場分析、洞察與預測
• 內視鏡止血裝置
• 內視鏡機械和設備
• 內視鏡熱凝裝置
• 閉合裝置
• 其他

第5章 全球消化道出血治療市場：依胃腸道細分市場分類

• 市場分析、洞察與預測
• 上消化道
• 下消化道

第6章：全球消化道出血治療市場：依發病時間分類

• 市場分析、洞察與預測
• 急性
• 慢性的

第7章 全球消化道出血治療市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心（ASC）
• 其他

第8章 全球消化道出血治療市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Boston Scientific Corporation
  • Conmed Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Medtronic PLC
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Pfizer Inc
  • STERIS PLC
  • US Medical Innovations

The Gastrointestinal Bleeding Treatment Market size is expected to reach USD 1.93 Billion in 2034 from USD 0.96 Billion (2025) growing at a CAGR of 8.06% during 2026-2034.

The gastrointestinal bleeding treatment market is witnessing growth due to the increasing incidence of gastrointestinal disorders, ulcers, and colorectal cancers. Aging populations and unhealthy lifestyles, including excessive alcohol consumption and poor dietary habits, are contributing to higher prevalence rates. Advances in diagnostic techniques are enabling early detection, thereby boosting demand for effective treatment solutions.

Key drivers include the adoption of minimally invasive endoscopic procedures, improved hemostatic devices, and expanding healthcare infrastructure in developing regions. Pharmaceutical therapies, blood transfusion services, and advanced surgical techniques are enhancing treatment outcomes. Growing awareness and improved emergency care services are further supporting market expansion globally.

Future growth will be driven by innovations in endoscopic therapies and targeted drug development. Increased healthcare spending and insurance coverage are expected to improve patient access to treatment. As medical technologies evolve and patient outcomes improve, the gastrointestinal bleeding treatment market is anticipated to maintain steady long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Endoscopic Hemostatic Devices
• Endoscopic Mechanical Devices
• Endoscopic Thermal Devices
• Closure Devices
• Other

By GI Tract Division

• Upper GI tract
• Lower GI tract

By Onset

• Acute
• Chronic

By End-use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Other

COMPANIES PROFILED

• Boston Scientific Corporation, Conmed Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc, STERIS PLC, US Medical Innovations
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Endoscopic Hemostatic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Endoscopic Mechanical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Endoscopic Thermal Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY GI TRACT DIVISION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Gi Tract Division
• 5.2. Upper GI tract Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Lower GI tract Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY ONSET 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Onset
• 6.2. Acute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Chronic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Gi Tract Division
  • 8.2.3 By Onset
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Gi Tract Division
  • 8.3.3 By Onset
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Gi Tract Division
  • 8.4.3 By Onset
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Gi Tract Division
  • 8.5.3 By Onset
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Gi Tract Division
  • 8.6.3 By Onset
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GASTROINTESTINAL BLEEDING TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Boston Scientific Corporation
  • 10.2.2 Conmed Corporation
  • 10.2.3 Cook Group
  • 10.2.4 ERBE Elektromedizin GmbH
  • 10.2.5 Medtronic PLC
  • 10.2.6 Olympus Corporation
  • 10.2.7 Ovesco Endoscopy AG
  • 10.2.8 Pfizer Inc
  • 10.2.9 STERIS PLC
  • 10.2.10 US Medical Innovations